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Conformationally preorganized peptide nucleic acids (PNAs) have been synthesized through backbone modiﬁcations at the γ-
position,whereR=alanine,valine,isoleucine,andphenylalaninesidechains.Theeﬀects oftheseside-chainsontheconformations
and hybridization properties of PNAs were determined using a combination of CD and UV-Vis spectroscopic techniques. Our
results show that the γ-position can accommodate varying degrees of sterically hindered side-chains, reaﬃrming the bimodal
function of PNAs as the true hybrids of “peptides” and “nucleic acids.”
1.Introduction
Oligonucleotidesare becoming increasingly important in the
postgenomic era, as molecular tools for basic research as
well as potential therapeutic and diagnostic reagents for the
treatment and detection of genetic diseases [1–4]. However,
for many of the in vivo applications, it is not suﬃced
just to be able to design oligonucleotide reagents that can
recognize and bind sequence speciﬁcally to DNA or RNA.
These reagents would also need to be able to get into cells
and withstand enzymatic degradation by nucleases in the
cellular milieu. To date, diverse classes of oligonucleotide
analogues have been developed, but none possesses all the
characteristic features [5–8]. It is, therefore, important to be
able to modify the structures and/or chemical functionalities
of these reagents further, with ease and ﬂexibility, so that
many of these desired features could be augmented and/or
improved upon [9, 10] and undesired attributes, such as
nonspeciﬁc binding and toxicity,couldbe further minimized
[11, 12].
A particular class of oligonucleotide analogue endowed
with such synthetic ﬂexibility ispeptide nucleicacids(PNAs)
[13]. PNAs are nucleic acid mimics, comprised of N-(2-
aminoethyl) glycine backbone and DNA/RNA nucleobases
that are connected through a ﬂexible carboxymethylene
linker. Despite the structural departure from the natural
biopolymers, PNAs maintain the ability to hybridize to
complementary DNA and RNA strands through Watson-
Crick base-pairing, just as their natural counterparts, but
with higher aﬃnity and sequence selectivity. The improve-
ment in binding aﬃnity has been attributed in part to
the lack of electrostatic repulsion in the backbones [14],
while the enhancement in sequence selectivity has been
attributed in part to the increased backbone rigidity upon
hybridization as the result of solvation [15, 16]. Unlike
DNA or RNA, which are prone to nucleolytic degrada-
tion, PNAs are resistant to both proteases and nucleases.
These properties, together with the ease and ﬂexibility of
synthesis, make PNAs an attractive commodity for in vivo
applications.
So far, a large number of structural modiﬁcations have
been made to the backbone of PNAs [17–21]. Among
them, modiﬁcations made at the γ-position show the most
promise because of the simplicity and ﬂexibility in synthesis
and the beneﬁts that they confer on the hybridization
properties of PNAs [22–28]. Recently, we showed that
randomly folded, single-stranded PNAs can be preorganized
into either a right-handed or left-handed helix by installing2 Journal of Nucleic Acids
an appropriate stereogenic centerat the γ-backbone position
[27–29]. γPNAs derived from L-amino acids adopted a
right-handed helix, while those derived from D-amino acids
adopted a left-handed helix (unpublished data); however,
only the right-handed helical γP N A sa r ea b l et oh y b r i d i z et o
DNA and RNA with high aﬃnity and sequence selectivity.
Although a number of amino acid side chains including
alanine [22, 23], serine [27], cysteine [25], and lysine [24,
26, 30] have been incorporated at this position, a systematic
study aimed at assessing the eﬀect of steric hindrance on the
conformations and hybridization properties ofPNAs has not
yetbeenestablished.Knowledgeofthisinformationiscrucial
to the future design of PNAs with improved hybridization
properties, water solubility, cellular uptake, biodistribu-
tion, and pharmacokinetics—all of which are essential for
their in vivo applications. In an attempt to address this
issue, we synthesized a series of thymine-containing γPNA
monomers and corresponding oligomers with diﬀerent
amino acid side chains at the γ-backbone position and
characterized their conformations and hybridization prop-
erties using a combination of CD and UV-Vis spectroscopic
techniques.
2.Materialsand Methods
2.1. Materials and Equipments. All commercial reagents
were used without further puriﬁcation. Solvents were dried
by standard methods and distilled immediately prior to
use. All chemicals were purchased from Aldrich except
for Boc-Val-OH, Boc-Phe-OH, Boc-Ala-OH, and Boc-
Ile-OH, which were purchased from Novabiochem. 1H-
NMR and 13C-NMR spectra were recorded on a Bruker
Avance AV-300 NMR spectrometer using standard Bruker
software. Column chromatography was performed using
standard grade silica gel from Sorbent Technologies. TLC
was performed with silica gel 60 F-254 precoated plates
from Sorbent Technologies. MALDI-TOF experiments were
performed on aPerSeptiveBiosystems Voyager STR MALDI-
TOF mass spectrometer using a 10mg/mL solution of α-
hydroxycinnamic acid in ACN-water (1:1) with 0.1% TFA.
Mass spectra were recorded on a Finnigan LCQ ESI/APCI
ion trap mass spectrometer by electrospray ionization. CD
experiments were performed on a Jasco J-715 spectropo-
larimeter equipped with a thermoelectrically controlled
single-cell holder. UV-Vis measurements were taken on a
Varian Cary 300 Bio spectrophotometer equipped with a
thermoelectrically controlled multicell holder. All Boc/Z-
protected PNA monomers were purchased from Applied
Biosystems. PNA1–9 oligomers were synthesized on solid-
support according to standard protocols [31]. The oligomers
were puriﬁed by reverse-phase HPLC and characterized by
MALDI-TOF. All PNA stock solutions were prepared using
nanopure water, and the concentrations were determined
at 95◦C using the following extinction coeﬃcients for
PNAmonomers: 13,700M−1 cm−1 (A), 6,600M−1 cm−1 (C),
11,700M−1 cm−1 (G), and 8,600M−1 cm−1 (T). The DNA
oligomers were purchased from Integrated DNA Technolo-
gies, Inc. and used without further puriﬁcation.
2.2. CD Analysis. The samples were prepared in buﬀer
containing 0.1mM EDTA, 100mM NaCl, 10mM sodium
phosphate at pH 7.4. The UV absorption at 260nm was
carefully adjusted at 95◦C so that each sample contained the
same concentration. All spectra represent an average of at
least twelve scans between 200–320nm, measured at the rate
of100nmperminina1-cmpath-lengthcuvetteat25◦C.The
spectra were baseline corrected and then smoothed using an
eight-point adjacent averaging algorithm.
2.3. Thermal Denaturation Experiments. The samples were
prepared in the same buﬀer employed in the CD experi-
ments. UV-Vis absorbance at 260nm was recorded every
0.5◦C as the samples were cooled from 95◦Ct o2 0 ◦Ca n d
then heated to 95◦Ca tar a t eo f1 . 0 ◦C/min. Each Tm curve
was then normalized for absorbance reading.
2.4. Monomer Synthesis. Alanine derivatives 1–5a were
prepared according to published procedures [27]. 5a:
HRMS (ESIMSm/z)M calc for C17H26N4NaO4 421.17, found
412.1344.
Boc-Val-ol (1b). Boc-Val-OH (501mg, 2.31mmoL) was
dissolved in a cold (−15◦C) solution of dimethoxyethane
(DME) (5mL). N-methyl morpholine (NMM) (0.25mL,
2.27mmoL) and isobutyl chloroformate (0.30mL,
2.30mmoL) were added dropwise to the mixture. The
solution was allowed to stir for 1min. The precipitated
N-methyl morpholine hydrochloride was removed by
vacuum ﬁltration and washed with DME (3 × 2mL).The
ﬁltrate and washing solutions were recombined, cooled to
−15◦C in a methanol ice bath. To this mixture, a solution of
NaBH4 (0.130g, 3.45mmoL) in water (0.5mL) was added
dropwise (producing evolution of gas). The mixture was
allowed to stir for 1 min, and approximately 100mL of
water was added to quench the reaction. The solution was
then transferred to a separatory funnel and extracted with
ethyl acetate (EtOAc) (3 × 50mL) and then brine (1 ×
100mL). The organic layers were combined and dried over
anhydrous sodium sulfate. The solvent was then removed
under reduced pressure to give 450mg (2.21mmoL, 97%
yield) of the desired product 1b as pale yellow oil. TLC: rf
= 0.65 (6:4 EtOAc:hexane). 1H-NMR (CDCl3, 300MHz):
δ = 0.80–1.06 (6H, m, CH(CH3)2); 1.49 (9H, s, C(CH3)3);
1.85 (1H, m, CH(CH3)2); 2.25 (1H, br, CH2OH); 3.50 (1H,
m, NCHCO); 3.76 (2H, m, CH2OH); 4.65 (1H, br, CONH).
Minor solventimpuritieswere found in the 1H-NMR:EtOAc
(1.30, 2.10, and 4.12), H2O (1.60), Acetone (2.20), and DME
(3.40 and 3.60). (ESI-MS m/z) mass calculated 203.28 for
C10H21NO3, found 226.07 (203.28 + Na+).
Boc-Ile-ol (1c). Synthesis is analogous to that of 1b,s t a r t i n g
from Boc-Ile-OH (499.6mg, 2.08mmoL), NMM (0.23mL,
2.09mmoL), isobutyl chloroformate (0.27mL, 2.08mmoL),
and NaBH4 (0.12g, 3.17mmoL). 430mg (1.99mmoL, 95%
yield) of 1c was obtained as colorless oil. TLC: rf =
0.65 (6:4 EtOAc:hexane). 1H-NMR (CDCl3, 300MHz):
δ = 0.80–1.00 (6H, m, CHCH3,C H C H 2CH3); 1.20–1.40Journal of Nucleic Acids 3
(2H, m, CHCH2CH3); 1.49 (9H, s, C(CH3)3); 1.60 (1H,
m, CHCH2CH3); 2.25 (1H, br, CH2OH); 3.50 (1H, m,
NCHCO); 3.76 (2H, m, CH2OH); 4.65 (1H, br, CONH).
Minor impurities were found in the 1H-NMR: Isobutyl
chloroformate (0.9, 2.0, 3.90), EtOAc (1.30, 2.10, and 4.12),
and H2O (1.60). (ESI-MS m/z) mass calculated 217.31 for
C11H23NO3, found 240.31 (217.31 + Na+).
Boc-Phe-ol (1d). Synthesis is analogous to that of 1b,
starting from Boc-Phe-OH (500mg, 1.89mmoL), NMM
(0.21mL, 1.91mmoL), isobutyl chloroformate (0.25mL,
1.93mmoL), and NaBH4 (0.11g, 2.91mmoL). 410mg
(1.63mmoL, 86% yield) of 1d was obtained as colorless
oil. TLC: rf = 0.65 (6:4 EtOAc:hexane). 1H-NMR (CDCl3,
300MHz):δ =1.49(9H,s,C(CH3)3);2.25(1H,br,CH2OH);
2.85 (2H, m, CHCH2Ph); 3.50 (1H, m, NCHCO); 3.76
(2H, m, CH2OH); 4.75 (1H, br, CONH); 7.25–7.40 (5H,
m, CH2PhH2–6). Minor impurities were found in the 1H-
NMR:Isobutylchloroformate(0.90,2.00,3.90),EtOAc(1.30,
2.10, and 4.12), H2O (1.60), and Acetone (2.20). (ESI-MS
m/z) mass calculated 251.32 for C14H21NO3, found 252.0
and 274.13 (251.32 + Na+).
Ethyl N-(o-nitrophenylsulfonyl) glycinate (Nos-Gly-OEt). It
was prepared following the reported procedures [23].
Boc-Valψ[CH2N(Nos)]Gly-OEt (2b). 1b (450mg, 2.21
mmoL), Nos-Gly-OEt (475mg, 1.65mmoL), and triphen-
ylphosphine (Ph3P) (653mg, 2.49mmoL) were dissolved in
freshly distilled dry THF (25mL). The solution was stirred
in an ice bath under nitrogen. Diisopropyl azodicarboxylate
(DIAD) (0.5mL, 2.54mmoL) was added dropwise over
10min. The reaction was stirred under nitrogen overnight.
The solvent was removed under a reduced pressure. The
oily product was puriﬁed by column chromatography (3:7
EtOAc:hexane, rf = 0.65) to give 700mg (1.48mmoL, 90%
yield) of 2b. 1H-NMR (CDCl3, 300MHz): δ = 0.90–1.00
(6H, m, CH(CH3)2); 1.25 (3H, t, OCH2CH3,J= 7.1Hz);
1.49 (9H, s, C(CH3)3); 1.80 (1H, m, CH(CH3)2); 3.45–3.80
(3H, m, NCHCH2N); 4.00–4.20 (2H, m, OCH2CH3);
4.40–4.65 (2H, m, NCH2CO); 6.30 (1H, br, NH); 7.60–7.80
(3H, m, ArH4–6); 8.10 (1H, m, ArH3). Minor impurities
were found in the 1H-NMR: DIAD byproduct (1.30, 5.00,
6.30), H2O (1.60), and Acetone (2.20). (ESI-MS m/z) mass
calculated 473.54 for C20H31N3O8S, found 496.13(473.54 +
Na+).
Boc-Ileψ[CH2N(Nos)]Gly-OEt (2c). Synthesis is analogous
to that of 2b,s t a r t i n gf r o m1c (430mg, 1.99mmoL),
Nos-Gly-OEt (436mg, 1.51mmoL), and Ph3P (604mg,
2.30mmoL). The reaction was stirred under nitrogen for
48hrs. The solvent was removed, and the oily product
mixture was puriﬁed by column chromatography (3:7
EtOAc:hexane, rf = 0.68) to give 649mg (1.33mmoL, 88%
yield)of 2c. 1H-NMR(CDCl3,300MHz):δ =0.80–1.00(6H,
m, CHCH3,C H C H 2CH3), 1.10 (2H, m, CHCH2CH3); 1.20
(3H, t, OCH2CH3,J= 7.1Hz); 1.49 (9H, s, C(CH3)3); 1.60
(1H,m,CHCH2CH3);3.45–3.80(3H,m,NCHCH2N);4.00–
4.20(2H,m,OCH2CH3);4.40–4.65(2H,m,NCH2CO);6.30
(1H, br, NH); 7.60–7.80 (3H, m, ArH4–6); 8.10 (1H, m,
ArH3). Minor impurities were found in the 1H-NMR: DIAD
byproduct(1.30,5.00,6.30),H2O(1.60),andAcetone(2.20).
(ESI-MS m/z) mass calculated 487.57 for C21H33N3O8S,
found 510.57 (487.57 + Na+).
Boc-Pheψ[CH2N(Nos)]Gly-OEt (2d). Synthesis is analogous
to that of 2b,s t a r t i n gf r o m1d (410mg, 1.63mmoL),
Nos-Gly-OEt (402mg, 1.39mmoL), and Ph3P (528mg,
2.01mmoL). The reaction was stirred under nitrogen
overnight. The solvent was removed, and the oily product
mixture was puriﬁed by column chromatography (3:7
EtOAc:hexane, rf = 0.70) to give 560mg (1.07mmoL, 77%
yield) of 2d. 1H-NMR (CDCl3, 300MHz): δ = 1.20 (3H, t,
OCH2CH3 J=7 . 1H z ) ;1 . 4 9( 9 H ,s ,C ( C H 3)3); 2.85 (2H, m,
CHCH2Ph); 3.50–3.70 (3H, m, NCHCH2N ) ;4 . 0 2( 1 H ,m ,
CHCH2Ph); 4.30 (2H, m, NCH2CO); 6.30 (1H, br, NH);
7.10–7.40 (5H, m, CH2PhH2–6); 7.65–7.80 (3H, m, oNBS
ArH4–6); 7.90 (1H, m, oNBS ArH3). Minor impurities
were found in the 1H-NMR: DIAD byproduct (1.30, 5.00,
6.30), H2O (1.60), and Acetone (2.20). (ESI-MS m/z) mass
calculated 521.58 for C24H31N3O8S, found 544.13 (521.58 +
Na+).
Boc-Valψ(CH2N)Gly-OEt (3b). 2b (700mg, 1.48mmoL)
was dissolved in acetonitrile (25mL) under nitrogen. Dried
potassium carbonate (440mg, 3.13mmoL) was added to the
solution. While stirring thiophenol (0.450mL, 4.40mmoL)
was added dropwise over the course of 3min. The mixture
was vigorously stirred overnight. The resulting mixture was
gravity-ﬁltered to remove excess potassium carbonate and
the solvent removed under reduced pressure. The crude
product was dissolved in 100mL EtOAc, washed with water
(2 × 100mL), followed by brine (1 × 50mL). The organic
layers were recombined and dried over anhydrous sodium
sulfate. The solvent was removed under reduced pressure.
The crude product was puriﬁed by column chromatography
(20:1 EtOAc:EtOH, rf = 0.15) to give 200mg (0.69mmoL,
47% yield). 1H-NMR(CDCl3, 300MHz):δ = 0.90–1.00(6H,
m, CH(CH3)2); 1.25 (3H, t, OCH2CH3,J= 7.1Hz); 1.49
(9H, s, C(CH3)3); 1.80 (1H, m, CH(CH3)2); 2.65 (2H, m,
CHCH2NH); 3.40 (2H, AB, NCH2CO, J=17.4Hz); 3.50 (1H,
m, NCHCH2); 4.10–4.30 (2H, q, OCH2CH3,J= 7.2Hz);
4.60 (1H, br, Boc NH). 13CN M R( C D C l 3,7 5 M H z ) :δ =
172.5, 156.2, 77.2, 60.7, 55.5, 50.9, 30.5, 28.4, 19.3, 18.2,
14.2. (ESI-MS m/z) mass calculated 288.38 for C14H28N2O4,
found 289.07.
Boc-Ileψ(CH2N)Gly-OEt (3c). Synthesis is analogous to that
of 3b,s t a r t i n gf r o m2c (649mg, 1.33mmoL), potassium
carbonate (426mg, 3.08mmoL), and thiophenol (0.420mL,
4.11mmoL). The reaction was stirred under nitrogen for
48hrs. The solvent was removed under reduced pressure
after gravity ﬁltration. Analogous workup was performed
as for compound 4b. The crude product was puriﬁed
by column chromatography (EtOAc, rf = 0.15) to give4 Journal of Nucleic Acids
300mg (0.99mmoL, 75% yield) of oily product. 1H-
NMR (CDCl3, 300MHz): δ = 0.80–1.00 (6H, m, CHCH3,
CHCH2CH3), 1.15 (2H, m, CHCH2CH3); 1.30 (3H, t,
OCH2CH3,J = 7.1Hz); 1.49 (9H, s, C(CH3)3); 1.60 (1H,
m, CHCH2CH3); 2.65 (2H, m, CHCH2NH); 3.40 (2H, AB,
NCH2CO, J = 17.4Hz); 3.70 (1H, m, NCHCH2); 4.10–4.30
(2H, q, OCH2CH3,J= 7.2Hz); 4.60 (1H, br, Boc NH). 13C
NMR (CDCl3,7 5M H z ) :δ = 172.5, 156.1, 77.2, 60.7, 54.5,
50.9, 50.3, 37.2, 28.4, 25.4, 15.2, 14.2, 11.6. (ESI-MS m/z)
mass calculated 302.41 for C21H33N3O8S, found 303.00.
Boc-Pheψ(CH2N)Gly-OEt (3d). S y n t h e s i si sa n a l o g o u st o
thatof 3b,startingfrom2d(560mg,1.07mmoL),potassium
carbonate (398mg, 2.88mmoL), and thiophenol (0.400mL,
3.91mmoL). After workup and column puriﬁcation, 300mg
(0.89mmol, 83%yield)of 3d(20:1EtOAc:EtOH,rf = 0.15)
was obtained. 1H-NMR (CDCl3, 300MHz): δ = 1.20 (3H,
t, OCH2CH3,J= 7.1Hz); 1.49 (9H, s, C(CH3)3); 2.65 (2H,
m, CHCH2NH); 2.85 (2H, m, CHCH2Ph); 3.40 (2H, AB,
NCH2CO, J = 17.4Hz); 3.80 (1H, m, NCHCH2); 4.10–4.30
(2H, q, OCH2CH3,J= 7.2Hz); 4.60 (1H, br, Boc NH); 7.10–
7.40 (5H, m, CH2PhH2–6). Minor impurities were found in
the 1H-NMR: H2O (1.60). 13CN M R( C D C l 3,7 5 M H z ) :δ
= 172.4, 155.6, 138.0, 129.4, 128.4, 126.4, 77.2, 60.8, 51.6,
51.0, 39.1, 28.4, 14.2. (ESI-MS m/z) mass calculated 336.43
for C18H28N2O4, found 337.07.
Boc-Valψ[CH2N(ThyAc)]Gly-OEt (4b). Thymin-1-ylacetic
acid (154mg, 0.84mmoL), N, N , Dicyclohexylcarbodi-
imide (DCC) (176mg, 0.85mmoL), and 3-hydroxy-1,2,3-
benzotriazin-4(3H)-one (DhbtOH) (137mg, 0.84mmoL)
were dissolved in 10mL dry N,N-Dimethylformamide
(DMF). The mixture was stirred under nitrogen at room
temperature for 1hr. Then, 3b (200.0mg, 0.69mmoL),
which was dissolved in dry DMF (2 × 2.5mL), was added
dropwise into the mixture. The reaction mixture was heated
at 50◦C for 24hrs. After TLC veriﬁcation, the mixture was
gravity-ﬁltered and washed with DMF. The solvent was
removed under reduced pressure. The crude mixture was
dissolved in 100mL EtOAc and then washed with 100mL of
saturated NaHCO3 solution. The organic layer was set aside,
andtheNaHCO3 layerwaswashedwithEtOAc(2×100mL).
The organic layers were recombined and washed with 10%
KHSO4 (3 × 50mL), followed by saturated NaHCO3 (3 ×
50mL) and then brine (1 × 100mL). The organic layer was
dried over anhydrous sodium sulfate and the solvent was
removed under reduced pressure. The product was puriﬁed
bycolumnchromatography(EtOAc,rf =0.45)togive100mg
(0.22mmoL, 32% yield) of the desired product. 1H-NMR
(DMSO, 300MHz): δ = 0.90–1.00 (6H, m, CH(CH3)2); 1.20
(3H, t, OCH2CH3,J= 7.1Hz); 1.49 (9H, s, C(CH3)3); 1.70
(1H, m, CH(CH3)2); 1.80 (3H, s, Thymine CH3); 2.90–3.60
(2H, m, CHCH2NCO)∗; 3.45–3.60 (1H, m, NCHCH2)∗;
3.70 and 3.90 (2H, m, NCH2CO)∗; 4.14–4.22 (2H, q,
OCH2CH3,J= 7.2Hz); 4.40 and 4.70 (2H, 2AB, NCOCH2,
J = 7.6 and 16.6Hz)∗; 6.60 and 6.80 (1H, 2d, Boc-NH,J=
9.4 and 9.7Hz)∗;7 . 2 0( 1 H ,s ,T h y m i n eH ); 11.20 (1H, 2s,
Thymine-NH)∗. Minor impurities were found in the 1H-
NMR: EtOAc (1.20, 2.00, 4.00), H2O (3.30), and DhbtOH
byproduct (5.50). (ESI-MS m/z) mass calculated 454.52 for
C21H34N4O7, found 477.20 (454.52 + Na+). (∗1t o2m i x e d
rotameric species in solution.)
Boc-Ileψ[CH2N(ThyAc)]Gly-OEt (4c). Synthesis is analo-
gous to that of 4b, starting with thymin-1-ylacetic acid
(223mg, 1.21mmoL), DCC (251mg, 1.22mmoL), and
DhbtOH (196mg, 1.20mmoL) dissolved in 10mL dry DMF.
A f t e rs t i r r i n gf o r1 h ra tr o o mt e m p e r a t u r e ,3c (300mg,
0.99mmol) was dissolved in dry DMF (2 × 2.5mL) and
added dropwise. The mixture was heated at 50◦Cf o r4 8h r s .
After workup and puriﬁcation by column chromatogra-
phy (20:1 EtOAc:EtOH, rf = 0.45), 300mg (0.64mmoL,
65% yield) of the desired product was obtained. 1H-
NMR (DMSO, 300MHz): δ = 0.80–1.00 (6H, m, CHCH3,
CHCH2CH3); 1.10 (2H, m, CHCH2CH3); 1.20 (3H, t,
OCH2CH3,J= 7.1Hz); 1.49 (9H, s, C(CH3)3); 1.60 (1H, m,
CHCH2CH3);1.80(3H,s,Thymine CH3);2.90–3.70(2H,m,
CHCH2NCO)∗; 3.95 and 4.00 (1H, 2m, NCHCH2)∗; 4.05–
4.12 (2H, m, NCH2CO)∗; 4.14–4.22 (2H, q, OCH2CH3,J
= 7.2Hz); 4.40 and 4.70 (2H, 2AB, NCOCH2,J= 7.6 and
16.6Hz)∗; 6.65 and 6.82 (1H, 2d, Boc-NH,J= 9.4 and
9.7Hz)∗;7 . 2 0( 1 H ,s ,T h y m i n eH ); 11.20 (1H, 2s, Thymine-
NH)∗. Minor impurities were found in the 1H-NMR: EtOAc
(1.20, 2.00, 4.00), DMF (2.70 and 2.90), H2O (3.30), and
DhbtOH byproduct (5.50). (ESI-MS m/z) mass calculated
468.54 for C22H36N4O7, found 491.13 (468.54 + Na+). (∗1
to 2 rotameric species in solution.)
Boc-Pheψ[CH2N(ThyAc)]Gly-OEt (4d). Synthesis is analo-
gous to that of 4b, starting with thymin-1-ylacetic acid
(198mg, 1.08mmoL), DCC (228mg, 1.11mmoL), and
DhbtOH (186mg, 1.14mmoL) dissolved in 10mL dry DMF.
After stirring for 1hr at room temperature, a solution of
3d (300.0mg, 0.60mmoL) in dry DMF (2 × 2.5mL) was
added dropwise. The mixture was heated at 50◦Cf o r2 4h r s .
After workup and puriﬁcation by column chromatography
(20:1 EtOAc:EtOH rf = 0.55), 280mg (0.56mmoL, 93%
yield) of 4d was obtained. 1H-NMR (DMSO, 300MHz): δ
= 1.20 (3H, t, OCH2CH3,J= 7.1Hz); 1.49 (9H, s, C(CH3)3);
1.80 (3H,s, Thymine CH3); 2.60–2.85(2H, m, CHCH2Ph)∗;
3.05–3.50 (2H, m, CHCH2NCO)∗; 3.80 and 3.95 (1H, 2m,
NCHCH2)∗; 4.00–4.15 (2H, m, NCH2CO)∗;4 . 2 0( 2 H ,q ,
OCH2CH3,J= 7.2Hz); 4.50 and 4.70 (2H, 2AB, NCOCH2 J
= 16.1 and 16.6Hz)∗; 6.75and 6.90 (1H,2d, Boc-NH,J= 8.7
and 9.4Hz)∗; 7.10–7.30 (6H, m, CH2PhH2–6 and Thymine
H)); 11.20 (1H, 2s, Thymine-NH)∗. Minor impurities were
found in the 1H-NMR: EtOAc (1.20, 2.00, 4.00), EtOH (1.10
and 3.60), H2O (3.30),and DhbtOH byproduct (5.50).(ESI-
MS m/z) mass calculated 502.56 for C25H34N4O7,f o u n d
530.47 (502.56 + Na+). (∗1t o2r o t a m e r i cs p e c i e si n
solution.)
Boc-Valψ[CH2N(ThyAc)]Gly-OH (5b). 4b (100mg, 0.22
mmoL) was dissolved in tetrahydrofuran (THF) (3mL). The
solution was stirred and cooled to 0◦Ci na ni c eb a t ha n dJournal of Nucleic Acids 5
followed by dropwise addition of 2M NaOH (3mL). After
conﬁrming by TLC that the reaction has gone to completion,
water (25mL) was added to quench the reaction. The mix-
ture was extracted with EtOAc (2 × 100mL). The aqueous
layer was then acidiﬁed with 1M HCl (aq) solution to pH 3.
The solution was then extracted with EtOAc (3 × 100mL)
and then dried over anhydrous sodium sulfate. The solvent
was then removed under reduced pressure. Ether was added
to the solution, resulting in precipitation of the monomer.
The white precipitate was ﬁltered oﬀ and puriﬁed by column
chromatography (8:2 DCM:MeOH,rf =0.40)togive51mg
(0.12mmoL, 54% yield) of white crystalline product. m.p:
210–213◦C (decomposition). 1H-NMR (DMSO, 500MHz):
δ = 0.90–1.00 (6H, m, CH(CH3)2); 1.49 (9H, s, C(CH3)3);
1.70 (1H, m, CH(CH3)2); 1.80 (3H, s, Thymine CH3); 3.00,
3.20, 3.45, 3.55 (2H, 4m, CHCH2NCO)∗; 3.50 and 3.60 (1H,
2m, NCHCH2)∗;3.70 and 3.85(2H,2AB,NCH2CO,J = 17.4
and 18.2Hz)∗; 4.45 and 4.70 (2H, 2AB, NCOCH2,J= 16.3
and 17.1Hz)∗; 6.60 and 6.90 (1H, 2d, Boc-NH,J= 9.4 and
9.7Hz)∗;7 . 2 0( 1 H ,s ,T h y m i n eH ); 11.20 (1H, 2s, COOH)∗.
13C NMR (DMSO, 75MHz): δ = 172.1, 168.2, 167.3, 164.9,
156.4, 156.2, 151.5, 142.6, 142.3, 108.5, 78.3, 77.9, 54.3, 54.1,
52.1, 49.5, 48.7, 48.0, 39.1, 30.6, 30.3, 28.7, 19.9, 19.0, 18.3,
12.4. (ESI-MS m/z) mass calculated 426.46 for C19H30N4O7,
found 449.20 (426.46 + Na+). (∗1t o2r o t a m e r i cs p e c i e s
in solution). HRMS (ESI/MSm/z)M calc for C19H30N4NaO7
449.20, found 449.1682.
Boc-Ileψ[CH2N(ThyAc)]Gly-OH (5c). S y n t h e s i si sa n a l o -
gous to that of 5b, starting with 4c (300mg, 0.68mmoL)
dissolved in THF (9mL). The solution was cooled to 0◦C,
and 2M NaOH (9mL) was added dropwise. To quench
the reaction 75mL of water was added. After extraction
and precipitation, the product was puriﬁed by column
chromatography (8:2 DCM:MeOH, rf = 0.40) to give
156mg (0.36mmoL, 52% yield) of 5c as white crystals. m.p:
210–213◦C (decomposition). 1H-NMR (DMSO, 500MHz):
δ = 0.80–1.00 (6H, m, CHCH3,C H C H 2CH3); 1.20–1.40
(2H, m, CHCH2CH3); 1.49 (9H, s, C(CH3)3); 1.60 (1H,
m, CHCH2CH3); 1.80 (3H, s, Thymine CH3); 3.00, 3.30,
3.50, 3.60 (2H, 4m, CHCH2NCO)∗; 3.55 and 3.65 (1H,
2m, NCHCH2)∗; 3.90 and 3.95 (2H, 2AB, NCH2CO, J =
16.5 and 18.7Hz)∗; 4.45 and 4.70 (2H, 2AB, NCOCH2,J
= 16.2 and 16.7Hz)∗; 6.60 and 6.90 (1H, 2d, Boc-NH,J=
9.2 and 9.5Hz)∗;7 . 2 0( 1 H ,s ,T h y m i n eH ); 11.20 (1H, 2s,
COOH)∗. 13C NMR (DMSO, 75MHz): δ = 171.8, 168.1,
167.5, 164.8, 156.2, 156.1, 151.5, 142.5, 142.2, 108.5, 78.3,
77.9, 53.3, 52.9, 51.7, 49.3, 48.9, 48.4, 48.0, 37.3, 28.7, 25.5,
25.2, 15.7, 12.4, 11.9, 11.5. (ESI-MS m/z) mass calculated
440.49 for C20H32N4O7, found 463.13 (440.49 + Na+). (∗1
to 2 rotameric species in solution.) HRMS(ESI/MSm/z)M calc
for C20H32N4NaO4 463.22, found 463.1957.
Boc-Pheψ[CH2N(ThyAc)]Gly-OH (5d). Synthesis is analo-
gous to that of 5b, starting with 4d (280mg, 0.56mmoL)
dissolved in THF (12mL). The solution was cooled to 0◦C
and 2M NaOH (12mL) was added dropwise. To quench
the reaction 75mL of water was added. After extraction
and precipitation, the product was puriﬁed by column
chromatography (8:2 DCM:MeOH, rf = 0.50) to give
150mg (0.32mmoL, 56% yield) of 5d as white crystals. m.p:
210–213◦C (decomposition). 1H-NMR (DMSO, 500MHz):
δ = 1.49 (9H, s, C(CH3)3); 1.80 (3H, s, Thymine CH3);
2.55, 2.65, 2.75, 2.85 (2H, 4AB, CHCH2Ph, J = 5.4 and 10.0
some peaks are obscured by H2Op e a k ) ∗; 3.00, 3.35, 3.40,
3.60(2H,4AB,CHCH2NCO,J∼6.5Hz)∗;3.75and 3.95(1H,
2m, NCHCH2)∗;3 . 9 0( 2 H ,m ,NC H 2CO)∗ and 4.0 (2H, AB,
NCH2CO, J = 17.8Hz)∗; 4.45 (2H, m, NCOCH2)∗ and 4.70
(2H, AB, NCOCH2,J= 16.4Hz)∗; 6.80 and 6.90 (1H, 2d,
Boc-NH,J=9.0and 9.4Hz)∗;7.10–7.30(6H,m,CH2PhH2–
6a n dT h y m i n eH ); 11.20 (1H, 2s, COOH)∗. 13CN M R
(DMSO, 75MHz): δ = 171.1, 168.3, 167.6, 164.8, 155.7,
151.5, 142.6, 139.6, 139.2, 129.5, 128.5, 128.4, 126.5, 126.3,
108.4, 78.4, 78.0, 51.7, 50.8, 48.7, 48.1, 46.0, 38.1, 28.7, 12.4,
10.3. (ESI-MS m/z) mass calculated 474.51 for C23H30N4O7,
found 497.07 (474.51 + Na+). (∗1t o2r o t a m e r i cs p e c i e s
in solution.) HRMS (ESI/MSm/z)M calc for C23H30N4NaO7
497.20, found 497.1580.
2.5. Oligomer Synthesis. The oligomers were synthesized
according to standard solid-phase procedures [31]. The
oligomers were cleaved from the resin with TFA/TFMSA/m-
cresol/thioanisole mixture (6:2:1:1), precipitated with
ethylether(4x),andthenair-dried.Theoligomerswerepuri-
ﬁed by reverse-phase HPLC and characterized by MALDI-
TOF mass spectrometry.
3.Resultsand Discussion
The following amino acid side chains, alanine (ala), valine
(val), isoleucine (ile), and phenylalanine (phe), were incor-
poratedattheγ-backboneposition ofPNA.Thecorrespond-
ing thymine monomers were prepared from their respective
Boc-protected L-amino acids according to the procedures
outlined in Scheme 1. Mitsunobu coupling reaction was
chosen over reductive amination in the preparation of the
backbone intermediates because it is less prone to racem-
ization. These chiral building blocks were then individually
incorporated into the PNA oligomers using standard solid-
phase synthesis procedures [31]. After cleavage from the
resin, the oligomers were puriﬁed by reverse-phase HPLC
(See Figures S1a–S9a, in Supplementary Material available
online at doi: 10.4061/2011/652702) and characterized by
MALDI-TOF mass spectrometry (Figures S1b–S9b).
CD measurements were recorded at 5μMs t r a n dc o n c e n -
tration each in sodium phosphate buﬀer (10mM sodium
phosphate, 0.1mM EDTA and 100mM NaCl, pH 7.4) at
room temperature. Inspection of Figure 1 reveals that all
PNAoligomerscontaining γ-backbonemodiﬁcations(PNA2
through 5) exhibited biphasic exciton coupling patterns,
characteristic of a right-handed helix [32]. Nonoticeable CD
signals were observed in the nucleobase absorption regions
(220–300nm) for the unmodiﬁed PNA (PNA1). This is
expected since unmodiﬁed, single-stranded PNA does not
have a well-deﬁned helical conformation [27]. We ruled out6 Journal of Nucleic Acids
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Scheme 1: Synthesis of thymine-containing γPNA monomers. Reagents and conditions: (a) iBuOCOCl, NMM, DME, −20◦C, then
NaBH4/H2O, −20◦C; (b) Nos-Gly-OEt, Ph3P, DIAD, THF, 0 ◦C→RT; (c) PhSH, K2CO3,C H 3CN, RT; (d) Thy-AcOH, DCC, DhbtOH, DMF,
40◦C;(e)2MNaOH:THF(1:1),15min(0 ◦C), then neutralized with 1M HCl.
thepossibilityofPNAadoptinganequimolarratioofaright-
handed and left-handed helix as suggested by MD simu-
lations [33], based on multinuclear and multidimensional
NMR analyses [27]. The similarity in the CD proﬁles of
PNA2 through 5 suggests that variations in the amino acid
side chains at the γ-position have little eﬀect on the overall
conformationofγPNAs.Thesubtlediﬀerencesinthe240nm
minima generallyindicatevariationsinthehelicalpitch,with
the positive minima characteristic of a more relaxed PNA-
PNA [34] and the negative minima characteristic of a more
tightly wound PNA-DNA duplex [35]. The variations in the
degree of winding are likely to be the result of steric clash,
with the largest phenylalanine side-chain expected to induce
the greatest eﬀect.
To better understand how these side chains aﬀect the
hybridization properties of γPNAs, we measured their
melting transitions (Tms) following hybridization with an
antiparallel, complementary DNA strand. Our data showed
that incorporation of each γ-building block resulted in an
increase in the Tm of the hybrid duplex by ∼4
oCf o ra l l
four amino acid side chains examined (Table 1), consistent
with the CD data. Next, we examined the eﬀects of backbone
spacing on the conformations and hybridization properties
of γPNAs. We selected phenylalanine (phe) because it is
the most sterically hindered side-chain among this group,
which is likely to cause the greatest steric clash. PNA6
contained three phe groups placed in alternate positions
with the unmodiﬁed PNA units, while PNA7 also contained
three phe groups but they were placed consecutively next to
one another. The two oligomers showed similar CD proﬁles
(Figure 2) but with varied signal strengths, with PNA6 (phe
3alt) exhibiting stronger signals than PNA7 (phe 3con). It
is interesting to note that PNA5, which contained one phe
group, showed similar CD proﬁle as that of PNA7, which
beared three phe groups. This result indicates that one phe
side-chain is suﬃcient to preorganize PNA into a helical
motif.
UV melting data showed that PNA6 binds less tightly
to a complementary DNA strand than PNA7, with the ΔTm
of +11 and +13◦C, respectively, compared to that of the
unmodiﬁed PNA-DNA. This result is unexpected because
PNA6 seems more organized (or better base-stacked) based
on the CD data. It should therefore be able to bind more
eﬀectively with its complementary DNA strand. The fact
that it is not suggests that other factors may play a role.
O n ep o s s i b l es o u r c eo fe x t r aa ﬃnity for PNA7 may come
from interstrand interactions. The three phe rings placed
in the consecutive arrangement might be able to interact
with the adjacent DNA bases better than those placed in
the alternate positions. Such interactions help anchor PNA
onto the DNA strand. A second possibility may come from
the fact that the phe rings are able to stack better with one
another in the consecutive than in the alternate arrangement
upon hybridization with the complementary DNA strand.
This provides a more favorable solvophobic driving force
for PNA7-DNA to remain in the duplex form rather than
dissociate into individual strands. A third possibility may
come from the diﬀerence in the rigidity of the two helices.
Since PNA6 is more rigid than PNA7, as inferred from the
CDdata,itislessaccommodatingtotheDNAstrand—which
may explain the lower Tm.
To delineate these three possible eﬀects, we synthesized
another set of γPNA oligomers (PNA8 and PNA9) with
valine side-chain at the γ-position. Val and phe side chains
are similar in size but they diﬀer in their ability to
i n t e r a c tw i t ho n ea n o t h e r .T h ep h es i d ec h a i n sc a nπ-
stack with one another whereas the val side chains cannot.
Therefore, comparing the CD and Tm proﬁles of the twoJournal of Nucleic Acids 7
Table 1: Tms of PNA-DNA hybrid duplexes containing perfectly matched sequence.
Name Sequence Tm (◦C) ΔTm (◦C)
PNA1 (Unmod) H-GCATGTTTGA-LLys-NH2 47 —
PNA2 (Ala) H-GCATGTTTGA-LLys-NH2 51 +4
PNA3 (Val) H-GCATGTTTGA-LLys-NH2 51 +4
PNA4 (Ile) H-GCATGTTTGA-LLys-NH2 51 +4
PNA5 (Phe) H-GCATGTTTGA-LLys-NH2 51 +4
PNA6 (Phe 3alt) H-GCATGTTTGA-LLys-NH2 58 +11
PNA7 (Phe 3con) H-GCATGTTTGA-LLys-NH2 60 +13
PNA8 (Val3alt) H-GCATGTTTGA-LLys-NH2 55 +8
PNA9 (Val3con) H-GCATGTTTGA-LLys-NH2 55 +8
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Figure 1: CD spectra of PNA1 through 5. Otherwise stated, all
the samples for CD and UV-melting experiments were prepared
in buﬀer containing 10mM sodium phosphate, 0.1mM EDTA,
100mMNaCl atpH = 7.4.The concentrationofoligomerwas5μM
strand each. The CD spectra were recorded at 25◦C. Inset: UV-Vis
spectra of PNA1 through 5 at 90◦C, demonstrating that they had
t h es a m ec o n c e n t r a t i o n .T : modiﬁed monomer with the indicated
side-chain.
sets of oligomers should provide insights into the role
of π-π interaction between the phe side chains on the
conformations and stability of the hybrid duplex. Our
result shows that both PNA8 (val PNA alt) and PNA9 (val
PNA con) have the same Tm (55◦C) (Figure 3, Table 1)
suggesting that the extra binding aﬃnity of PNA6 (phe
alt) and PNA7 (phe con) comes from π-π interaction.
However, it is not clear at this point whether the phe ring
stacking occurs intramolecularly with the adjacent PNA
bases or intermolecularly with the DNA bases—both of
which produce similar results. The same CD patterns were
observedfor the secondset of oligomers, with the alternating
PNA8 exhibiting greater CD signal than the consecutively
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Figure 2: CD spectra of PNA1, 5, 6, and 7. The CD spectra were
recorded at 25◦C.Inset:UV-Visspectra ofPNA1,5,6,and7at90◦C.
T: modiﬁed monomer with phe side-chain.
modiﬁedPNA9(Figure 4).Itisnotobviouswhy thealternate
arrangement displayed greater helical character than their
consecutive counterparts. One possible explanation is that
the “helical directors,” in this case the stereogenic centers
at the γ-backbone position, are more spread out in the
alternate than in the consecutive arrangement. The alternate
arrangement, therefore, should enable the “helical directors”
to induce and propagate the helical sense of the oligomer
more eﬀectively than the consecutive arrangement, since
each chiral director has fewer achiral units in front of them
to direct. This explanation is consistent with the “Sergeants
and Soldiers” concept proposed by Green and coworkers
[36, 37] to explain helical induction in polymers. When
comparing the two arrangements it should be noted that
although they both start out at the same position (the third
unit from the C-terminus), the alternate sequence contained
γ-building blocks that are spread out further toward the
N-terminus. This should give them greater advantage in
organizing the remaining achiral, N-terminal residues since8 Journal of Nucleic Acids
Table 2: Tms( ◦C) of PNA-DNA hybrid duplexes containing
perfectly matched and single-base mismatched sequences.
Oligomer X = A T (ΔTm)G ( ΔTm)C ( ΔTm)
PNA1 (Unmod.) 47 35 (−12) 32 (−15) 31 (−16)
PNA2 (Ala) 51 40 (−11) 34 (−17) 33 (−18)
PNA3 (Val) 51 40 (−11) 34 (−17) 33 (−18)
PNA4 (Ile) 51 39 (−12) 34 (−17) 33 (−18)
PNA5 (Phe) 51 40 (−11) 35 (−16) 35 (−16)
PNA6 (Phe 3alt) 58 45 (−13) 42 (−16) 39 (−19)
PNA7 (Phe 3con) 60 47 (−13) 41 (−19) 41 (−19)
PNA8 (Val3alt) 55 41 (−14) 37 (−18) 38 (−17)
PNA9 (Val3con) 55 42 (−13) 37 (−18) 39 (−16)
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Figure 3: UV-melting proﬁles of PNA1, 3, 8, and 9 following
hybridization with a complementary DNA strand. The concentra-
tion of each oligomer was 5μM. Both the heating and cooling runs
were performed. They showed nearly identical proﬁles. T: modiﬁed
monomerwith phe side-chain.
our previous study showed that helical induction occurs in
a unidirectional fashion from C-t oN-terminus [27]. This
may explain why γPNAs with the alternate placement exhibit
greater CD signals, hence more helical character, than those
with the consecutive arrangement. Detailed explanations
for this phenomenon will await further structural studies.
Nevertheless, this result shows that the chiral backbone units
can be placed in the consective or alternative position with
minimal eﬀect on the oligomer’s binding aﬃnity, unless the
side-chain contains an aromatic group which slightly favors
the consecutive arrangement.
In addition to the perfect match, we have determined the
melting transitions for the PNA-DNA hybrid duplexes con-
taining single-base mismatched binding sites (see Table 2).
Our result shows that conformationally preorganized γPNAs
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Figure 4: CD spectra of PNA1, 3, 8, and 9. The spectra were
recorded at 25◦C.Inset:UV-Visspectra ofPNA1,3,8,and9at90◦C.
T: modiﬁed monomer with phe side-chain.
can discriminate between related sequences, with similar
degree ofspeciﬁcity asthat oftheunmodiﬁed PNAoligomer.
The ΔTms for mismatched duplexes range from −11 to
−19◦C, depending on the mismatch pair with T-T mismatch
being the least discriminating. Though incorporation of
additional γ-backbone modiﬁed units further improved the
binding aﬃnity of PNAs towards complementary DNA
strands, it does not signiﬁcantly aﬀect their ability to
discriminate single-base mismatched sequences. This result
shows that the binding aﬃnity of PNA can be improved
by installing an appropriate stereogenic center at the γ-
backbone position without compromising sequence speci-
ﬁcity.
In summary, we have shown that a number of amino
acid side chains with varying degree of steric hindrance
can be placed at the γ-position of the N-(2-aminoethyl)
glycine backbone of PNA without inducing adverse aﬀect
on the hybridization properties of PNAs. Spectroscopic
measurements showed that these PNA oligomers adopted
a right-handed helix and hybridized to a complementary
DNA strand with higher aﬃnity than their unmodiﬁed
counterpart, with ΔTm ∼ +4◦C per unit incorporated.
Despite their strong binding aﬃnities, these conformation-
ally preorganized γPNAs can discriminate related sequences,
with similar level of speciﬁcity as that of the unmodiﬁed
PNA. Placement of the chiral γ-units (consecutive versus
alternating) has subtle eﬀects on the conﬁrmations and
hybridization properties of γPNA oligomers depending on
whether the side chains are involved in intramolecular π-
π stacking; but overall, these eﬀects are negligible. Our
results conﬁrm that PNAs are true hybrids of peptides and
nucleic acids, capable of binding DNA (and RNA), and
can be functionalized with a number of amino acid sideJournal of Nucleic Acids 9
chains without inducing adverse aﬀects on the hybridization
properties of the oligomers. The ability to modify the
structures and chemical functionalities of oligonucleotide
analogues is important because it allows other functional
properties beside hybridization, such water solubility, cel-
lular uptake, biodistribution, and pharmacokinetics to be
augmented and/or further improved upon and undesired
features, such nonspeciﬁc binding and toxicity, to be further
minimized. The ease and ﬂexibility of synthesis, along with
superior hybridization properties and enzymatic stability,
make γPNAs an attractive nucleic acid platform for various
biological and medical applications—as molecular tools as
well as therapeutic and diagnostic reagents.
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